How can we measure immunologic tolerance in humans?

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2652-2663

  Najafian, Nader ^a,c   Albin, Monica J ^a   Newell, Kenneth A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; IMMUNOSUPPRESSIVE AGENT; T LYMPHOCYTE RECEPTOR; TETRAMER;

B LYMPHOCYTE; CELL PROLIFERATION; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 33749263016     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005070707     Document Type: Review

References (76)

1. Sayegh MH, Carpenter CB: Transplantation 50 years later: Progress, challenges, and promises. N Engl J Med 351: 2761-2766, 2004
2. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003
3. Meier-Kriesche HU, Schold JD, Kaplan B: Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4: 1289-1295, 2004
4. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4: 378-383, 2004
5. Eason JD, Cohen AJ, Nair S, Alcantera T, Loss GE: Tolerance: Is it worth the risk? Transplantation 79: 1157-1159, 2005
6. Burdick JF, Beschorner WE, Smith WJ, McGraw D, Bender WL, Williams GM, Solez K: Characteristics of early routine renal allograft biopsies. Transplantation 38: 679-684, 1984
7. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353: 2342-2351, 2005
8. Newell KA, Larsen CP, Kirk AD: Transplant tolerance: Converging on a moving target. Transplantation 81: 1-6, 2006
9. Sayegh MH, Turka LA: The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338: 1813-1821, 1998
10. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y: Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 6: 686-688, 2000
11. Zhou P, Hwang KW, Palucki D, Kim O, Newell KA, Fu YX, Alegre ML: Secondary lymphoid organs are important but not absolutely required for allograft responses. Am J Transplant 3: 259-266, 2003
12. Chalasani G, Dai Z, Konieczny BT, Baddoura FK, Lakkis FG: Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A 99: 6175-6180, 2002
13. Ng WF, Hernandez-Fuentes M, Baker R, Chaudhry A, Lechler RI: Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 13: 2983-2989, 2002
14. Lechler R, Chai JG, Marelli-Berg F, Lombardi G: The contributions of T-cell anergy to peripheral T-cell tolerance. Immunology 103: 262-269, 2001
15. Rothstein DM, Sayegh MH: T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 196: 85-108, 2003
16. Clarkson MR, Sayegh MH: T-cell costimulatory pathways in allograft rejection and tolerance. Transplantation 80: 555-563, 2005
17. Adams AB, Larsen CP, Pearson TC, Newell KA: The role of TNF receptor superfamily molecules in organ transplantation. Am J Transplant 2: 12-18, 2002
18. Khoury SJ, Sayegh MH: The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20: 529-538, 2004
19. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B; Belatacept Study Group: Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353: 770-781, 2005
20. Larsen CP, Pearson TC, Adams AB, Tso P, Shirasugi N, Strobertm E, Anderson D, Cowan S, Price K, Naemura J, Emswiler J, Greene J, Turk LA, Bajorath J, Townsend R, Hagerty D, Linsley PS, Peach RJ: Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 5: 443-453, 2005
21. Jiang S, Lechler RI: Regulatory T cells in the control of transplantation tolerance and autoimmunity. Am J Transplant 3: 516-524, 2003
22. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3: 199-210, 2003
23. Torrealba JR, Katayama M, Fechner JH Jr, Jankowska-Gan E, Kusaka S, Xu Q, Schultz JM, Oberley TD, Hu H, Hamawy MM, Jonker M, Wubben J, Doxiadis G, Bontrop R, Burlingham WJ, Knechtle SJ: Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol 172: 5753-5764, 2004
24. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH: Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14: 1643-1651, 2003
25. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG: Human allograft acceptance is associated with immune regulation. J Clin Invest 106: 145-155, 2000
26. Bennett CL, Ochs HD: IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr Opin Pediatr 13: 533-538, 2001
27. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M: Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6: 464-469, 2000
28. Adams AB, Durham MM, Kean L, Shirasugi N, Ha J, Williams MA, Rees PA, Cheung MC, Mittelstaedt S, Bingaman AW, Archer DR, Pearson TC, Waller EK, Larsen CP: Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol 167: 1103-1111, 2001
29. Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB: Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 74: 1405-1409, 2002
30. Kawai T, Cosimi AB, Wee SL, Houser S, Andrews D, Sogawa H, Phelan J, Boskovic S, Nadazdin O, Abrahamian G, Colvin RB, Sach DH, Madsen JC: Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 73: 1757-1764, 2002
31. Wekerle T, Kurtz J, Sayegh M, Ito H, Wells A, Bensinger S, Shaffer J, Turka L, Sykes M: Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol 166: 2311-2316, 2001
32. Valujskikh A, Pantenburg B, Heeger PS: Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2: 501-509, 2002
33. Lombardi G, Sidhu S, Daly M, Batchelor JR, Makgoba W, Lechler RI: Are primary alloresponses truly primary? Int Immunol 2: 9-13, 1990
34. Forman D, Welsh RM, Markees TG, Woda BA, Mordes JP, Rossini AA, Greiner DL: Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms. J Immunol 168: 6047-6056, 2002
35. Adams AB, Pearson TC, Larsen CP: Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 196: 147-160, 2003
36. Li Y, Li XC, Zheng XX, Wells AD, Turka LA, Strom TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 5: 1298-1302, 1990
37. Battaglia M, Stabilini A, Roncarolo MG: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105: 4743-4748, 2005
38. Goldstein DR, Tesar BM, Akira S, Lakkis FG: Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 111: 1571-1578, 2003
39. Vella JP, Spadafora-Ferreira M, Murphy B, Alexander SI, Harmon W, Carpenter CB, Sayegh MH: Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplantation 64: 795-800, 1997
40. Ciubotariu R, Liu Z, Colovai AI, Ho E, Itescu S, Ravalli S, Hardy MA, Cortesini R, Rose EA, Suciu-Foca N: Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 101: 398-405, 1998
41. Reznik SI, Jaramillo A, SivaSai KS, Womer KL, Sayegh MH, Trulock EP, Patterson GA, Mohanakumar T: Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 1: 228-235, 2001
42. Burlingham WJ, Grailer AP, Fechner JH Jr, Kusaka S, Trucco M, Kocova M, Belzer FO, Sollinger HW: Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 59: 1147-1155, 1995
43. Weimar W, Rischen-Vos J, de Kuiper P, Gregoor PJ, IJzermans JN, van Besouw NM, Baan CC, van der Mast BJ: Tapering immunosuppression in recipients of living donor kidney transplants. Nephrol Dial Transplant 19[Suppl]: iv61-iv63, 2004
44. Najafian N, Salama AD, Fedoseyeva EV, Benichou G, Sayegh MH: Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13: 252-259, 2002
45. Gebauer BS, Hricik DE, Atallah A, Bryan K, Riley J, Tary-Lehmann M, Greenspan NS, Dejelo C, Boehm BO, Hering BJ, Heeger PS: Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2: 857-866, 2002
46. Hricik DE, Rodriguez V, Riley J, Bryan K, Tary-Lehmann M, Greenspan N, Dejelo C, Schulak JA, Heeger PS: Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 3: 878-884, 2003
47. Poggio ED, Clemente M, Riley J, Roddy M, Greenspan NS, Dejelo C, Najafian N, Sayegh MH, Hricik DE, Heeger PS: Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. J Am Soc Nephrol 15: 1952-1960, 2004
48. Pelletier RP, Hennessy PK, Adams PW, Orosz CG: High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. Am J Transplant 2: 926-933, 2002
49. Rodriguez DS, Jankowska-Gan E, Haynes LD, Leverson G, Munoz A, Heisey D, Sollinger HW, Burlingham WJ: Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 4: 537-543, 2004
50. Kita H, He XS, Gershwin ME: Application of tetramer technology in studies on autoimmune diseases. Autoimmun Rev 2: 43-49, 2003
51. Cai J, Lee J, Jankowska-Gan E, Derks R, Pool J, Mutis T, Goulmy E, Burlingham WJ: Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199: 1017-1023, 2004
52. Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA: Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J Immunol 166: 973-981, 2001
53. Tanaka Y, Ohdan H, Onoe T, Mitsuta H, Tashiro H, Itamoto T, Asahara T: Low incidence of acute rejection after living-donor liver transplantation: Immunologic analyses by mixed lymphocyte reaction using a carboxyfluorescein diacetate succinimidyl ester labeling technique. Transplantation 79: 1262-1267, 2005
54. Pala P, Hussell T, Openshaw PJ: Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243: 107-124, 2000
55. Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk. Am J Transplant 3: 1488-1500, 2003
56. Rifle G, Mousson C, Martin L, Guignier F, Hajji K: Donor-specific antibodies in allograft rejection: Clinical and experimental data. Transplantation 79[Suppl]: S14-S18, 2005
57. Mulder A, Kardol MJ, Kamp J, Uit Het Broek C, Schreuder GM, Doxiadis II, Claas FH: Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol 124: 9-15, 2001
58. Zand MS, Bose A, Vo T, Coppage M, Pellegrin T, Arend L, Lee FE, Bozorgzadeh A, Leong N: A renewable source of donor cells for repetitive monitoring of T- and B-cell alloreactivity. Am J Transplant 5: 76-86, 2005
59. Li Y, Koshiba T, Yoshizawa A, Yonekawa Y, Masuda K, Ito A, Ueda M, Mori T, Kawamoto H, Tanaka Y, Sakaguchi S, Minato N, Wood KJ, Tanaka K: Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4: 2118-2125, 2004
60. Cortesini R, Renna-Molajoni E, Cinti P, Pretagostini R, Ho E, Rossi P, Suciu-Foca Cortesini N: Tailoring of immunosuppression in renal and liver allograft recipients displaying donor specific T-suppressor cells. Hum Immunol 63: 1010-1018, 2002
61. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW: Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3: 689-696, 2003
62. Mazariegos GV, Zahorchak AF, Reyes J, Chapman H, Zeevi A, Thomson AW: Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5: 314-322, 2005
63. Guillet M, Brouard S, Gagne K, Sebille F, Cuturi MC, Delsuc MA, Soulillou JP: Different qualitative and quantitative regulation of V beta TCR transcripts during early acute allograft rejection and tolerance induction. J Immunol 168: 5088-5095, 2002
64. Brouard S, Dupont A, Giral M, Louis S, Lair D, Braudeau C, Degauque N, Moizant F, Pallier A, Ruiz C, Guillet M, Laplaud D, Soulillou JP: Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 5: 330-340, 2005
65. Kowalski R, Post D, Schneider MC, Britz J, Thomas J, Deierhoi M, Lobashevsky A, Redfield R, Schweitzer E, Heredia A, Reardon E, Davis C, Bentlejewski C, Fung J, Shapiro R, Zeevi A: Immune cell function testing: An adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17: 77-88, 2003
66. Zeevi A, Britz JA, Bentlejewski CA, Guaspari D, Tong W, Bond G, Murase N, Harris C, Zak M, Martin D, Post DR, Kowalski RJ, Elmagd KA: Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl Immunol 15: 17-24, 2005
67. Li B, Hartono C, Ding R, Sharma VK, Ramaswamy R, Qian B, Serur D, Mouradian J, Schwartz JE, Suthanthiran M: Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 344: 947-954, 2001
68. Mansfield ES, Sarwal MM: Arraying the orchestration of allograft pathology. Am J Transplant 4: 853-862, 2004
69. Moser KL, Gaffney PM, Grandits ME, Emamian ES, Machado DB, Baechler EC, Rhodus NL, Behrens TW: The use of microarrays to study autoimmunity. J Investig Dermatol Symp Proc 9: 18-22, 2004
70. Flechner SM, Kurian SM, Head SR, Sharp SM, Whisenant TC, Zhang J, Chismar JD, Horvath S, Mondala T, Gilmartin T, Cook DJ, Kay SA, Walker JR, Salomon DR: Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4: 1475-1489, 2004
71. Flechner SM, Kurian SM, Solez K, Cook DJ, Burke JT, Rollin H, Hammond JA, Whisenant T, Lanigan CM, Head SR, Salomon DR: De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 4: 1776-1785, 2004
72. Fathman CG, Soares L, Chan SM, Utz PJ: An array of possibilities for the study of autoimmunity. Nature 435: 605-611, 2005
73. LaBaer J, Ramachandran N, Barry R, Soloviev M, Rocken C, Ebert MP, Roessner A: Protein microarrays as tools for functional proteomics. Curr Opin Chem Biol 9: 14-19, 2005
74. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15: 219-227, 2004
75. Salama AD, Remuzzi G, Harmon WE, Sayegh MH: Challenges to achieving clinical transplantation tolerance. J Clin Invest 108: 943-948, 2001
76. Matthews JB, Ramos E, Bluestone JA: Clinical trials of transplant tolerance: Slow but steady progress. Am J Transplant 3: 794-803, 2003